English
Home > Products > Nalmefene API

China Nalmefene API Factory

Our primary objective is usually to offer our shoppers a serious and responsible small business relationship, offering personalized attention to all of them for Nalmefene API,CAS NO 58895-64-0,58895-64-0,Nalmefene, Leading the trend of this field is our persistent objective. Supplying 1st class products and solutions is our intention. To make a beautiful long term, we would want to cooperate with all friends at your house and abroad. Should you've any interest within our products, remember to usually do not be reluctant to get in touch with us.
Nalmefene API, Relying on superior quality and excellent post-sales, our items sell well in America, Europe, the Middle East and South Africa. We're also the appointed OEM factory for several worlds' famous merchandise brands. Welcome to contact us for further negotiation and cooperation.

Related Products

Hot Products

  • Keratin hydrolyzed

    Keratin hydrolyzed

    Product Name:Keratin hydrolyzed
    Molecular Formula:C2H2BrClO2
    Molecular Weight:173.39308
    CAS Registry Number:69430-36-0
  • Mitomycin C

    Mitomycin C

    Product Name:Mitomycin C
    Molecular Formula:C15H18N4O5
    Molecular Weight;334.33
    CAS Registry Number;50-07-7
  • 4-Fluoro-2-nitrobenzeneamine

    4-Fluoro-2-nitrobenzeneamine

    Product Name:4-Fluoro-2-nitrobenzeneamine
    Molecular Formula:C6H5FN2O2
    Molecular Weight:156.11
    CAS Registry Number:364-78-3
  • 9-Anthracenemethanol

    9-Anthracenemethanol

    Product Name:9-Anthracenemethanol
    Molecular Formula:C15H12O
    Molecular Weight:208.26
    CAS Registry Number:1468-95-7
  • (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine

    (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine

    Product Name:(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine
    Molecular Formula:C13H10BrCl2FN2O
    Molecular Weight:380.04
    CAS Registry Number:877399-00-3
  • Letermovir N-3

    Letermovir N-3

    Product Name:Letermovir N-3
    Molecular Formula:C19H16F4N2O4
    Molecular Weight:412.33
    CAS Registry Number:917389-26-5
  • Related Blog
  • Reviews

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept